Cargando…

Editorial: Definition of the immune parameters related to COVID-19 severity

Detalles Bibliográficos
Autores principales:	Tincati, Camilla, de Vries, Rory, Jesenak, Milos, Marchetti, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172665/ https://www.ncbi.nlm.nih.gov/pubmed/37180170 http://dx.doi.org/10.3389/fimmu.2023.1204125

Ejemplares similares

Definition of the Immune Parameters Related to COVID-19 Severity
por: Birindelli, Sarah, et al.
Publicado: (2022)

Corrigendum: Definition of the immune parameters related to COVID-19 severity
por: Birindelli, Sarah, et al.
Publicado: (2023)

Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness
por: Tincati, Camilla, et al.
Publicado: (2020)

Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis
por: Jesenak, Milos, et al.
Publicado: (2020)

Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection
por: Tincati, Camilla, et al.
Publicado: (2016)

Editorial: Dysregulation of immunity predisposing to severe COVID-19 infection
por: Halwani, Rabih, et al.
Publicado: (2022)

Editorial: The relationship between COVID-19 severity and cancer immunity and immunotherapy
por: Nunès, Jacques A., et al.
Publicado: (2023)

Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2016)

Immunologic Interplay Between HIV/AIDS and COVID-19: Adding Fuel to the Flames?
por: Augello, Matteo, et al.
Publicado: (2023)

Activated CD8(+)CD38(+) Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
por: Bobcakova, Anna, et al.
Publicado: (2022)

Editorial: Modulation of Human Immune Parameters by Anticancer Therapies
por: Sack, Ulrich, et al.
Publicado: (2020)

Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes
por: Ancona, Giuseppe, et al.
Publicado: (2021)

Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022)

Editorial: Modulation of human immune parameters by anticancer therapies, volume II
por: Na, Il-Kang, et al.
Publicado: (2023)

Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
por: Rovito, Roberta, et al.
Publicado: (2022)

Evidence for Polymicrobic Flora Translocating in Peripheral Blood of HIV-Infected Patients with Poor Immune Response to Antiretroviral Therapy
por: Merlini, Esther, et al.
Publicado: (2011)

Editorial: Targeting the microbiota to attenuate chronic inflammation
por: Moreno, Elena, et al.
Publicado: (2023)

Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023)

Is weak CD4+ gain in the course of suppressive combination antiretroviral therapy for HIV infection a current clinical challenge? A case report and brief review of the literature
por: Tincati, Camilla, et al.
Publicado: (2018)

Editorial: Innate immunity and severe asthma: From microbiome to target therapy
por: Bagnasco, Diego, et al.
Publicado: (2022)

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders
por: Fiorillo, Maria Teresa, et al.
Publicado: (2019)

Editorial: Immune-Related Non-Communicable Diseases in Africa
por: Barbouche, Mohamed-Ridha, et al.
Publicado: (2022)

Editorial: Immune determinants of COVID-19 protection and disease: A focus on asymptomatic COVID and long COVID
por: Polyak, Maria J., et al.
Publicado: (2023)

Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
por: Kzhyshkowska, Julia, et al.
Publicado: (2023)

Towards a consensus definition of immune exclusion in cancer
por: Tiwari, Ankur, et al.
Publicado: (2023)

Editorial: Immunomodulatory Effects of Drugs for Treatment of Immune-Related Diseases
por: Maghazachi, Azzam A.
Publicado: (2017)

Editorial: Immune regulation and intervention in virus-related tumor development
por: Mo, Qinglin, et al.
Publicado: (2023)

Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
por: Basilissi, Matteo, et al.
Publicado: (2019)

Editorial: Stress and Immunity
por: Bae, Yong-Soo, et al.
Publicado: (2019)

Editorial: Fibrinolysis in Immunity
por: Kolev, Krasimir, et al.
Publicado: (2020)

Editorial: Complement and COVID-19 Disease
por: Prohászka, Zoltán, et al.
Publicado: (2022)

Editorial: The IL-20 Cytokines and Related Family Members in Immunity and Diseases
por: Niess, Jan Hendrik, et al.
Publicado: (2019)

Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020)

Editorial: Innate immunity and cross-talk with microflora in the regulation of immune recognition and polarization during immune-related diseases
por: Zhu, Haitao, et al.
Publicado: (2023)

Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation
por: Jakobs, Kai, et al.
Publicado: (2022)

A Longitudinal Study of Immune Cells in Severe COVID-19 Patients
por: Payen, Didier, et al.
Publicado: (2020)

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19
por: Zhang, Qiong, et al.
Publicado: (2021)

Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
por: Rendeiro, André F., et al.
Publicado: (2022)

The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
por: Kuijpers, Yunus, et al.
Publicado: (2022)

Immune and ionic mechanisms mediating the effect of dexamethasone in severe COVID-19
por: Chimote, Ameet A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqr0toecvfo5cg4invdm7ok5hu